The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases-Reference-Cited by-同舟云学术

The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases

Published:2018 Issue:3 Volume:16 Page:409
ISSN:1598-9100
Container-title:Intestinal Research
language:en
Short-container-title:Intest Res

Author:

Sanagapalli Santosh¹,Ko Yanna¹,Kariyawasam Viraj¹,Ng Siew C²,Tang Whitney²,de Silva Hithanadura Janaka³,Chen Minhu⁴,Wu Kaichun⁵,Aniwan Satimai⁶,Ng Ka Kei⁷,Ong David⁸,Ouyang Qin⁹,Hilmi Ida¹⁰,Simadibrata Marcellus¹¹,Pisespongsa Pises¹²,Gopikrishna Saranya¹,Leong Rupert W¹,

Affiliation:

1. Gastroenterology and Liver Services, Concord Repatriation General Hospital, Concord NSW, Australia.

2. Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, Li Ka Shing Institute of Health Science, Hong Kong, China.

3. Faculty of Medicine, University of Kelaniya, Ragama, Sri Lanka.

4. The First Affiliated Hospital of Sun Yat Sen University, Guangzhou, China.

5. Xijing Hospital, Fourth Military Medical University, Xian, China.

6. King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

7. Hospital Conde S Januario, Macau, China.

8. National University Hospital of Singapore, Singapore.

9. West China Hospital, Sichuan University, Chengdu, China.

10. University of Malaya Medical Center, Kuala Lumpur, Malaysia.

11. University of Indonesia, Indonesia.

12. Maharaj Nakorn Chiangmai Hospital, Chiangmai, Thailand.

Funder

Ferring Pharmaceuticals, Hong Kong